Andrew York, J.D., Pharm.D.

Executive Director at Maryland Prescription Drug Affordability Board

Speaker

Andrew York, Pharm.D., J.D., is the Executive Director of the Maryland Prescription Drug Affordability Board, which is an independent agency charged with protecting Marylanders from the high costs of prescription drugs. Dr. York comes to the Board with more than a decade of experience in health policy, including extensive experience in prescription drug pricing reform. Most recently, he worked on prescription drug payment policy and drug pricing reform at the U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS). During his time in the Immediate Office of the Secretary, he served as Advisor to the Secretary, supported the Senior Advisor to the Secretary on Drug Pricing Reform, and was integral to implementing many of the policies outlined in the American Patients First drug pricing blueprint, including the direct to consumer (DTC) advertising rule and the rebate rule. At the CMS Innovation Center (CMMI), Dr. York worked on a portfolio of models related to drug pricing, including serving as a co-lead on the Most Favored Nation (MFN) Model, an innovative model that will test the impact of linking payments for drugs to international prices, and serving on the team that developed the Part D Senior Savings (PDSS) Model, a model that tests the impact of enhanced alternative Part D plan options that offer lower out-of-pocket costs for insulin. Dr. York also served as a professorial lecturer at the George Washington University (GWU) Milken Institute School of Public Health teaching Pharmaceutical Policy and as an adjunct faculty at the University of Maryland Eastern Shore (UMES) School of Pharmacy teaching Pharmacy Law. Dr. York earned his Pharm.D. from the University of Maryland School of Pharmacy and his J.D. from the University of Maryland Francis King Carey School of Law.